News & Updates
Filter by Specialty:

Is it safe for T1D patients to exercise after a meal?
Individuals with type 1 diabetes (T1D) may engage in postprandial exercise so long as they take necessary precautions (ie, prandial insulin reductions), suggests a study.
Is it safe for T1D patients to exercise after a meal?
19 Jul 2024
Novel tool spots potentially inappropriate prescribing in T2D
A new tool for identifying potentially inappropriate prescribing (PIP) in people with type 2 diabetes (T2D) has been validated in the outpatient setting, according to an Ethiopian study.
Novel tool spots potentially inappropriate prescribing in T2D
18 Jul 2024
INHALE-3 underpins alternate insulin delivery method for T1D
Findings from the phase IV INHALE-3 trial support inhaled insulin for the management of type 1 diabetes (T1D) in adults, underlining its role as an alternative insulin solution to enhance diabetes management.
INHALE-3 underpins alternate insulin delivery method for T1D
17 Jul 2024
Automated insulin delivery system beneficial for T2D management
An automated insulin delivery (AID) system appears to improve clinical outcomes in people with type 2 diabetes (T2D), with the pivotal SECURE-T2D trial showing substantial improvements in glycated haemoglobin, total daily insulin dose, and diabetes distress, without increasing the risk of hypoglycaemia.
Automated insulin delivery system beneficial for T2D management
16 Jul 2024
Pemvidutide gains MOMENTUM in phase II obesity trial
Pemvidutide, an investigational, peptide-based GLP-1/glucagon dual receptor agonist, gains traction in the booming obesity drug market, delivering significant weight loss reductions in nondiabetic individuals with overweight or obesity in the phase II MOMENTUM trial.